Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
457 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01096342 | Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 2 | Jun 18, 2014 | clinicaltrials |
| NCT02013830 | A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 4 | Jun 6, 2014 | clinicaltrials |
| NCT01189903 | Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients | unknown | Phase 2 / Phase 3 | — | National University Hospital, SingaporeOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00807950 | Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer | unknown | Phase 2 | 100 | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01097083 | Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma | terminated | Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00910741 | NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia | completed | Phase 1 / Phase 2 | 40 | NanoCarrier Co., Ltd.INDUSTRY | 2 | Jan 9, 2014 | clinicaltrials |
| NCT00242515 | T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) | unknown | Phase 1 / Phase 2 | 16 | National University Hospital, SingaporeOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | unknown | Phase 2 | 35 | National Cancer Centre, SingaporeOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00212069 | Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00416130 | Clinical Trial of SAHA in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00669773 | Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient | unknown | Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00697437 | Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | completed | Phase 2 | 10 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00809237 | Hydroxychloroquine and Gefitinib to Treat Lung Cancer | unknown | Phase 1 / Phase 2 | 71 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01204177 | Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) | completed | Phase 2 | 70 | BayerINDUSTRY | 4 | Sep 6, 2013 | clinicaltrials |
| NCT00862082 | Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 1 / Phase 2 | 14 | Proacta, IncorporatedINDUSTRY | 4 | Aug 23, 2013 | clinicaltrials |
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 16 | National Cancer Centre, SingaporeOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01736410 | A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | completed | Phase 2 | 30 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00077402 | Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | Cancer Therapeutics Research GroupOTHER | 3 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00716534 | Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 145 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Apr 29, 2013 | clinicaltrials |
| NCT00517790 | Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | AbbVie (prior sponsor, Abbott)INDUSTRY | 5 | Apr 5, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT00517920 | Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 44 | AbbVie (prior sponsor, Abbott)INDUSTRY | 4 | Jan 4, 2013 | clinicaltrials |
| NCT00212095 | Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00737360 | Phase II Study of TAS-106 to Treat Head and Neck Cancer | terminated | Phase 2 | 27 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 4 | Sep 5, 2012 | clinicaltrials |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 21, 2012 | clinicaltrials |
| NCT00212108 | A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 | completed | Phase 1 / Phase 2 | 22 | National University Hospital, SingaporeOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00675545 | A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients | completed | Phase 2 | 2 | National University Hospital, SingaporeOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00703378 | Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle | completed | Phase 1 / Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma(dtZ) | completed | Phase 2 | 56 | Gleneagles HospitalOTHER | 3 | Jul 21, 2011 | clinicaltrials |
| NCT00369447 | A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 52 | YM BioSciencesINDUSTRY | 3 | Jul 1, 2011 | clinicaltrials |
| NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | unknown | Phase 2 | 54 | National Cancer Centre, SingaporeOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT01341756 | Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | May 9, 2011 | clinicaltrials |
| NCT01340508 | Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Apr 22, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00330707 | Combined Use of BCG and Interferon Alpha in Bladder Cancer | completed | Phase 2 / Phase 3 | 140 | National University Hospital, SingaporeOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | completed | Phase 2 | 124 | Bristol-Myers SquibbINDUSTRY | 20 | Aug 10, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00169572 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | completed | Phase 2 | 492 | GlaxoSmithKlineINDUSTRY | 19 | May 10, 2010 | clinicaltrials |
| NCT01102361 | Ultrasound Based Transperineal Robotic Biopsy of the the Prostate(BxB) | unknown | Phase 1 / Phase 2 | 250 | Singapore General HospitalOTHER | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 43 | National University Hospital, SingaporeOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00690872 | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer | unknown | Phase 2 | 35 | National Cancer Centre, SingaporeOTHER | 1 | Jun 29, 2009 | clinicaltrials |
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | unknown | Phase 2 | 70 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00801411 | Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 318 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials